Stockscreener 앱 받기
15.37
1.65%
0.25
시간 외 거래:
15.27
-0.10
-0.65%
Dr Reddys Laboratories Ltd Adr 주식(RDY)의 최신 뉴스
Stock Market News Today Live Updates on December 20, 2024 : Top Gainers and Losers today on 20 December, 2024: Dr Reddys Laboratories, ICICI Bank, Tech Mahindra, Trent among most active stocks; Check full list here | Stock Market News - Mint
Coccidioidomycosis Drugs Market to Reach US$ 634.3 Million by 2034, Expanding at a CAGR of 4.9% | Fact.MR Report - GlobeNewswire Inc.
Teva Pharmaceutical ADR Gets Relative Strength Rating Upgrade - Investor's Business Daily
ADR, GDR Listings of Indian companies - Goodreturns
Asian Equities Traded in the US as American Depositary Receipts Edge Down in Wednesday Trading - MSN
NVO Stock Quote Price and Forecast - CNN
Weekly Upgrades and Downgrades - InvestorPlace
(PDF) The impact of Clinical Pharmacist Lead Collaborative Care on Quality Of Life of the Patients with Bipolar Disorder: A Unicenter Prospective, Randomization Study - ResearchGate
Asian Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading - MSN
Asian Equities Traded in the US as American Depositary Receipts Flat in Tuesday Trading - MSN
Asian Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading - MSN
Jharkhand Elections Phase 2: Richest candidate declares assets worth Rs 402 cr – Check list of top 10 wealthiest candidates - The Financial Express
Jharkhand Phase 2 Elections 2024: 122 candidates with serious criminal cases get tickets, shows ADR report - The Financial Express
Dr. Reddy's Laboratories Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next - Simply Wall St
Earnings call: Dr. Reddy's reports robust growth and strategic expansions By Investing.com - Investing.com Australia
Earnings call: Dr. Reddy's reports robust growth and strategic expansions - Investing.com India
Dr. Reddy's stock poised for recovery with new US launches and global OTC gains—BofA - Investing.com India
Dr. Reddy's stock poised for recovery with new US launches and global OTC gains—BofA By Investing.com - Investing.com South Africa
Dr Reddy's Q2 Results: Revenue Rises 17% To Rs 8,106 Crore - Business Today
Dr. Reddy’s Labs ADR earnings missed by $0.85, revenue topped estimates - Investing.com Australia
Dr Reddy's Q2 results: Net profit falls 15% to Rs 1,255 crore - Moneycontrol
Dr Reddy’s Q2FY25 earnings preview: Expectations of steady revenue growth but margins under pressure - MSN
Dr Reddys Q2FY25 earnings preview: Expectations of steady revenue growth but margins under pressure - Zee Business
Asian Equities Traded in the US as American Depositary Receipts Climb Higher Friday - MSN
BP Faces Price Forecast Cuts As Analysts Flag Weak Earnings And Rising Debt Challenges - Yahoo Finance
Dr Reddy's Labs shares down 80% today? DRL stock turns ex-split - Business Today
Maharashtra: 93% MLAs crorepatis, 60% with criminal cases against them – know the composition of outgoing assembly | Mint - Mint
Saudi Arabia Heparin Market Size & Outlook, 2023-2030 - Grand View Research
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading - MSN
Indian stock market: 8 things that changed for market overnight- Gift Nifty, US retail sales, ECB rate cut to Q2 results | Stock Market News - Mint
Infosys, Wipro ADRs down 3% on NYSE after Q2 results even as S&P, Dow drift near record-highs | Stock Market News - Mint
Q2 Results Updates: Infosys ADR Falls Over 3%, Wipro Down Over 4% - NDTV Profit
Top gainers and losers for today on October 16: HDFC Life, Dr Reddy’s Labs, Grasim lead NIFTY movers - Upstox
1:5 Stock Split By Large-Cap Pharma Stock; Record DateOct 28: Buy Dr Reddy's For Rs 7,300 Target - Goodreturns
Denmark Basal Cell Carcinoma Treatment Market Size & Outlook, 2030 - Grand View Research
Saudi Arabia Basal Cell Carcinoma Treatment Market Size & Outlook, 2030 - Grand View Research
Haryana Election 2024: 95 candidates have serious criminal cases against them, 11 with cases of crime against women, says report - The Financial Express
Side-effects of banned drug Nimesulide still reported in children: Report | Today News - Mint
Dr. Reddy’s Announces Share Subdivision Date - TipRanks
Dr Reddy's, Hetero sign voluntary licenses with Gilead for HIV drug - Business Standard
Haryana Elections 2024: Capt. Abhimanyu, Savitri Jindal among wealthiest candidates for October 5 polls | Mint - Mint
Assam: Mobile internet services to be disabled for eight hours on Sunday, here's why | Today News - Mint
Apni Party's Altaf Bukhari, BJP's Devender Rana among 3 richest candidates in Jammu and Kashmir assembly poll fray | Mint - Mint
Dr. Reddy's Laboratories Share Price Today Live Updates: Dr. Reddy's Laboratories Sees Minor Price Dip A... - The Economic Times
Dr. Reddy’s Empowers Employees with Stock Options - TipRanks
Dr. Reddy’s Labs Clears USFDA Inspection - TipRanks
0.34%
0.82%
자본화:
|
볼륨(24시간):